Diplomat Pharmacy, which operates the fourth largest specialty pharmacy in the US, raised $173 million by offering 13.3 million shares at $13, below the range of $14 to $16. Diplomat Pharmacy plans to list on the NYSE under the symbol DPLO. Credit Suisse, Morgan Stanley, J.P. Morgan and Wells Fargo Securities acted as lead managers on the deal.
